Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Change in Account Payables (2024 - 2025)

Historic Change in Account Payables for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to -$300000.0.

  • Connect Biopharma Holdings' Change in Account Payables fell 10408.16% to -$300000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year change of. This contributed to the annual value of -$1.9 million for FY2024, which is 6434.86% down from last year.
  • Per Connect Biopharma Holdings' latest filing, its Change in Account Payables stood at -$300000.0 for Q3 2025, which was down 10408.16% from $1.5 million recorded in Q2 2025.
  • Connect Biopharma Holdings' 5-year Change in Account Payables high stood at $1.5 million for Q2 2025, and its period low was -$1.8 million during Q1 2024.